California's highest court to consider whether drugmakers have 'duty to innovate'

A decision could change product liability law ​if it effectively required drugmakers to spend more to develop and ​quickly commercialize alternative products, sometimes called a "duty to innovate." The case ⁠was brought by about 24,000 HIV patients who took Gilead drugs made with ​tenofovir disoproxil fumarate, or TDF.